Renal Business Today

Journal Of The American Society Of Nephrology (JASN)

Phosphate-Binding Drug Does Not Improve Heart

WASHINGTON—High phosphate levels in the blood carry increased heart-related risks, but taking a drug that targets phosphate does not improve cardiovascular measures in patients with mild kidney disease, according to a study appearing in an upcoming issue of the Journal of ...More
April 19, 2013
Posted in News, Clinical & Pharma
Management of Anemia in Children on Dialysis Examined

WASHINGTON —Children on dialysis who have anemia and who require high doses of drugs to treat it have an increased risk of dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings ...More
March 8, 2013
Posted in News, Clinical & Pharma
Technique Removes Additional Toxins, Prolongs Lives

WASHINGTON—A technique that removes additional toxins during dialysis may prolong kidney failure patients’ lives, according to a clinical trial appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). In light of these results, the technique ...More
February 18, 2013
Posted in News, Clinical & Pharma
Factors Linked with Survival Differences Between Black, White Kidney Failure Patients

WASHINGTON—Complex socioeconomic and residential factors may account for differences in survival between Black and White kidney failure patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings ...More
January 18, 2013
Posted in Articles, Clinical & Pharma
New Target for Treating Prediabetes in Patients with Kidney Disease

WASHINGTON—Insulin resistance, or prediabetes, in individuals with kidney disease may be caused by the progressive retention of certain compounds that are normally excreted by the kidneys in healthy individuals, according to a study appearing in an upcoming issue of the ...More
December 20, 2012
Posted in News, Clinical & Pharma
Extending Steroid Treatment Does Not Benefit Children with Hard-to-Treat Kidney Disease

WASHINGTON—Extending steroid treatment for the most common form of kidney disease in children provides no benefit for preventing relapses or side effects, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The ...More
December 20, 2012
Posted in News, Clinical & Pharma
Problems with Mineral Metabolism Linked with Kidney Disease Progression

WASHINGTON—Abnormalities of mineral metabolism worsen with progressive chronic kidney disease (CKD) and are linked with a higher risk for kidney failure among African Americans, according to a study appearing in an upcoming issue of the Journal of the American Society of ...More
December 14, 2012
Posted in News, Clinical & Pharma
Severe Acute Kidney Injuries Rise Rapidly Nationwide

SAN FRANCISCO—Severe acute kidney injuries (AKI's) are becoming more common in the United States, rising 10 percent per year and doubling over the last decade, according to a retrospective study at the University of California, San Francisco (UCSF). ...More
December 7, 2012
Posted in News, Clinical & Pharma
Treating Coronary Heart Disease in Kidney Failure Patients

WASHINGTON—Among the two available procedures for opening blocked arteries surrounding the heart, one appears to be safer than the other for dialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). ...More
November 30, 2012
Posted in News, Clinical & Pharma
Kidney Disease Progresses Faster in African Americans Than Other Races

WASHINGTON—Among individuals with chronic kidney disease (CKD), African Americans experience faster progression of the disease during later stages compared with other races, according to a study appearing in an upcoming issue of the Journal of the American Society of ...More
November 30, 2012
Posted in News, Clinical & Pharma